Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MULTIMOD

Financiado

Cerrado

Multi layer network modules to identify markers for personalized medication in c...

Multi layer network modules to identify markers for personalized medication in complex diseases The symptoms of complex disease like allergy, obesity and cancer depend on the products of multiple interacting genes. High-throughput techniques have implicated hundreds of genes. There are also considerable individual variations... ver más

31/10/2012

LIU

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

Linköping University No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 7 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2012-10-31 No tenemos la información de la convocatoria

0% 69% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

7 Participantes

LIU

492.99K€ | Lider

Innovasjon Norge

N.D. | Participante

THE UNIVERSITY OF TENNESSEE

UGOT - GOETEBORGS UNIVERSITE...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PDC2021-121243-I00 PLATAFORMA DELFOS: SISTEMA DE INFORMACION PARA LA GESTION DE... 102K€ Cerrado

EYLCOMPDISSYSBIO A Computational Systems Biology Approach to Reveal the Molec... 100K€ Cerrado

BIO2012-40205 DESARROLLO DE SISTEMAS BIOINFORMATICAS, Y DE LOS METODOS COM... 304K€ Cerrado

PID2021-128317OB-I00 APRENDIZAJE AUTOMATICO Y COMPUTACION DE ALTAS PRESTACIONES P... 159K€ Cerrado

SAF2017-90781-REDI FOMENTO DEL USO DE LAS TECNOLOGIAS OMICAS EN MEDICINA PERSON... 79K€ Cerrado

BIO2010-17527 BIOMARCADORES: UNA APROXIMACION DE BIOINFORMATICA FUNCIONAL... 157K€ Cerrado

Líder del proyecto

Linköping University No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The symptoms of complex disease like allergy, obesity and cancer depend on the products of multiple interacting genes. High-throughput techniques have implicated hundreds of genes. There are also considerable individual variations. A clinical implication of this may be inadequate treatment response, which is increasingly recognized as a cause of increased suffering and costs. Ideally, physicians should be able to routinely personalize medication based on a few diagnostic markers. Finding such markers is a formidable challenge. We hypothesize that translational clinical studies based on high-throughput genomics, advanced computing and systems biology may help to identify markers for personalized medication in complex diseases. We organize disease-associated genes in networks that are analyzed in a top-down manner. First, modules of interacting genes with distinct biological functions are identified. Then the modules are dissected to find pathways and finally upstream genes with key regulatory functions. We use bioinformatic methods that were recently described by us in Nature Genetics and Nature Biotechnology. An important focus of this project is to develop these methods to form multi-layer modules that integrate information about disease-associated changes on the DNA, RNA and protein levels. Since these levels interact, studies of the different levels can be interactively used to cross-validate the modules. This involves both genetic and experimental studies, but the ultimate test of the modules will be if they can be used for clinical predictions. For example, changes in RNA expression may be caused by a single nucleotide polymorphism (SNP) in a regulatory region. If so, the corresponding protein is tried as a marker to personalize medication. We have chosen hay fever as a model of complex disease because it is common, well-defined and readily examined in clinical and experimental studies. However, the methods may be generally applicable to complex diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores